Cizzle Biotechnology Holdings PLC (LON:CIZ)
2.40p
Spriggl Score: Poor— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“US laboratory clearance opens the door; guaranteed royalty payments are now the make-or-break factor.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £12.7M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Cizzle Biotechnology Holdings PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free